Selected research
Industry Research
Depression Treatment Device Industry Research Report 2026
Market perspective
The global Depression Treatment Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Depression Treatment Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Depression Treatment Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Depression Treatment Device include Alpha-Stim, BrainsWay, Caputron Medical, Electromedical Products International, Inc., Fisher Wallace Laboratories, Flow Neuroscience, Flow Neuroscience AB, Ginger and INNOVATIVE NEUROLOGICAL Devices LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Depression Treatment Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Depression Treatment Device Market by Company
Alpha-Stim
BrainsWay
Caputron Medical
Electromedical Products International, Inc.
Fisher Wallace Laboratories
Flow Neuroscience
Flow Neuroscience AB
Ginger
INNOVATIVE NEUROLOGICAL Devices LLC
Magnus Medical
Neurolief
Neuronetics
NeuroStar
The Magstim Company Limited
Depression Treatment Device Segment by Type
Transcranial Direct Current Stimulation (tDCS)
Transcranial Random Noise Stimulation (tRNS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Alternating Current Stimulation (tACS)
Electroconvulsive therapy (ECT)
Others
Depression Treatment Device Segment by Application
Hospital
Clinic
Others
Depression Treatment Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Treatment Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Depression Treatment Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Treatment Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Depression Treatment Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Depression Treatment Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Depression Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Random Noise Stimulation (tRNS)
- Transcranial Pulsed Current Stimulation (tPCS)
- Transcranial Alternating Current Stimulation (tACS)
- Electroconvulsive therapy (ECT)
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Alpha-Stim
- BrainsWay
- Caputron Medical
- Electromedical Products International, Inc.
- Fisher Wallace Laboratories
- Flow Neuroscience
- Flow Neuroscience AB
- Ginger
- INNOVATIVE NEUROLOGICAL Devices LLC
- Magnus Medical
- Neurolief
- Neuronetics
- NeuroStar
- The Magstim Company Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Depression Treatment Device Market Size (2021-2032)
- 2.2.2 Global Depression Treatment Device Sales (2021-2032)
- 2.2.3 Global Depression Treatment Device Market Average Price (2021-2032)
- 2.3 Depression Treatment Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Transcranial Direct Current Stimulation (tDCS)
- 2.3.3 Transcranial Random Noise Stimulation (tRNS)
- 2.3.4 Transcranial Pulsed Current Stimulation (tPCS)
- 2.3.5 Transcranial Alternating Current Stimulation (tACS)
- 2.3.6 Electroconvulsive therapy (ECT)
- 2.3.7 Others
- 2.4 Depression Treatment Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Depression Treatment Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Depression Treatment Device Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Depression Treatment Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Depression Treatment Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Depression Treatment Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Depression Treatment Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Depression Treatment Device, Product Type & Application
- 3.8 Global Manufacturers of Depression Treatment Device, Established Date
- 3.9 Global Depression Treatment Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alpha-Stim
- 4.1.1 Alpha-Stim Company Information
- 4.1.2 Alpha-Stim Business Overview
- 4.1.3 Alpha-Stim Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alpha-Stim Depression Treatment Device Product Portfolio
- 4.1.5 Alpha-Stim Recent Developments
- 4.2 BrainsWay
- 4.2.1 BrainsWay Company Information
- 4.2.2 BrainsWay Business Overview
- 4.2.3 BrainsWay Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BrainsWay Depression Treatment Device Product Portfolio
- 4.2.5 BrainsWay Recent Developments
- 4.3 Caputron Medical
- 4.3.1 Caputron Medical Company Information
- 4.3.2 Caputron Medical Business Overview
- 4.3.3 Caputron Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Caputron Medical Depression Treatment Device Product Portfolio
- 4.3.5 Caputron Medical Recent Developments
- 4.4 Electromedical Products International, Inc.
- 4.4.1 Electromedical Products International, Inc. Company Information
- 4.4.2 Electromedical Products International, Inc. Business Overview
- 4.4.3 Electromedical Products International, Inc. Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
- 4.4.5 Electromedical Products International, Inc. Recent Developments
- 4.5 Fisher Wallace Laboratories
- 4.5.1 Fisher Wallace Laboratories Company Information
- 4.5.2 Fisher Wallace Laboratories Business Overview
- 4.5.3 Fisher Wallace Laboratories Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
- 4.5.5 Fisher Wallace Laboratories Recent Developments
- 4.6 Flow Neuroscience
- 4.6.1 Flow Neuroscience Company Information
- 4.6.2 Flow Neuroscience Business Overview
- 4.6.3 Flow Neuroscience Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Flow Neuroscience Depression Treatment Device Product Portfolio
- 4.6.5 Flow Neuroscience Recent Developments
- 4.7 Flow Neuroscience AB
- 4.7.1 Flow Neuroscience AB Company Information
- 4.7.2 Flow Neuroscience AB Business Overview
- 4.7.3 Flow Neuroscience AB Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Flow Neuroscience AB Depression Treatment Device Product Portfolio
- 4.7.5 Flow Neuroscience AB Recent Developments
- 4.8 Ginger
- 4.8.1 Ginger Company Information
- 4.8.2 Ginger Business Overview
- 4.8.3 Ginger Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ginger Depression Treatment Device Product Portfolio
- 4.8.5 Ginger Recent Developments
- 4.9 INNOVATIVE NEUROLOGICAL Devices LLC
- 4.9.1 INNOVATIVE NEUROLOGICAL Devices LLC Company Information
- 4.9.2 INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
- 4.9.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
- 4.9.5 INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
- 4.10 Magnus Medical
- 4.10.1 Magnus Medical Company Information
- 4.10.2 Magnus Medical Business Overview
- 4.10.3 Magnus Medical Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Magnus Medical Depression Treatment Device Product Portfolio
- 4.10.5 Magnus Medical Recent Developments
- 4.11 Neurolief
- 4.11.1 Neurolief Company Information
- 4.11.2 Neurolief Business Overview
- 4.11.3 Neurolief Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Neurolief Depression Treatment Device Product Portfolio
- 4.11.5 Neurolief Recent Developments
- 4.12 Neuronetics
- 4.12.1 Neuronetics Company Information
- 4.12.2 Neuronetics Business Overview
- 4.12.3 Neuronetics Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Neuronetics Depression Treatment Device Product Portfolio
- 4.12.5 Neuronetics Recent Developments
- 4.13 NeuroStar
- 4.13.1 NeuroStar Company Information
- 4.13.2 NeuroStar Business Overview
- 4.13.3 NeuroStar Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 NeuroStar Depression Treatment Device Product Portfolio
- 4.13.5 NeuroStar Recent Developments
- 4.14 The Magstim Company Limited
- 4.14.1 The Magstim Company Limited Company Information
- 4.14.2 The Magstim Company Limited Business Overview
- 4.14.3 The Magstim Company Limited Depression Treatment Device Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 The Magstim Company Limited Depression Treatment Device Product Portfolio
- 4.14.5 The Magstim Company Limited Recent Developments
5 Global Depression Treatment Device Market Scenario by Region
- 5.1 Global Depression Treatment Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Depression Treatment Device Sales by Region: 2021-2032
- 5.2.1 Global Depression Treatment Device Sales by Region: 2021-2026
- 5.2.2 Global Depression Treatment Device Sales by Region: 2027-2032
- 5.3 Global Depression Treatment Device Revenue by Region: 2021-2032
- 5.3.1 Global Depression Treatment Device Revenue by Region: 2021-2026
- 5.3.2 Global Depression Treatment Device Revenue by Region: 2027-2032
- 5.4 North America Depression Treatment Device Market Facts & Figures by Country
- 5.4.1 North America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Depression Treatment Device Sales by Country (2021-2032)
- 5.4.3 North America Depression Treatment Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Depression Treatment Device Market Facts & Figures by Country
- 5.5.1 Europe Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Depression Treatment Device Sales by Country (2021-2032)
- 5.5.3 Europe Depression Treatment Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Depression Treatment Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Depression Treatment Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Depression Treatment Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Depression Treatment Device Market Facts & Figures by Country
- 5.7.1 South America Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Depression Treatment Device Sales by Country (2021-2032)
- 5.7.3 South America Depression Treatment Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Depression Treatment Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Depression Treatment Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Depression Treatment Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Depression Treatment Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Depression Treatment Device Sales by Type (2021-2032)
- 6.1.1 Global Depression Treatment Device Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Depression Treatment Device Sales Market Share by Type (2021-2032)
- 6.2 Global Depression Treatment Device Revenue by Type (2021-2032)
- 6.2.1 Global Depression Treatment Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Depression Treatment Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Depression Treatment Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Depression Treatment Device Sales by Application (2021-2032)
- 7.1.1 Global Depression Treatment Device Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Depression Treatment Device Sales Market Share by Application (2021-2032)
- 7.2 Global Depression Treatment Device Revenue by Application (2021-2032)
- 7.2.1 Global Depression Treatment Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Depression Treatment Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Depression Treatment Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Depression Treatment Device Value Chain Analysis
- 8.1.1 Depression Treatment Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Depression Treatment Device Production Mode & Process
- 8.2 Depression Treatment Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Depression Treatment Device Distributors
- 8.2.3 Depression Treatment Device Customers
9 Global Depression Treatment Device Analyzing Market Dynamics
- 9.1 Depression Treatment Device Industry Trends
- 9.2 Depression Treatment Device Industry Drivers
- 9.3 Depression Treatment Device Industry Opportunities and Challenges
- 9.4 Depression Treatment Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst